Table: Daito -2024/25 group results

Daito Pharmaceutical

11/07/2025 07:31

Jul 11 (Reuters)- 
          Daito Pharamaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              May 31, 2025    May 31, 2024   May 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           50.64           46.90          52.50                 
               (+8.0 pct)      (+4.0 pct)     (+3.7 pct)               
  Operating        2.62            3.89           3.00                 
               (-32.7 pct)     (-25.2 pct)    (+14.5 pct)              
  Recurring        2.71            3.92           3.00                 
               (-31.0 pct)     (-24.1 pct)    (+10.9 pct)              
  Net
  Net              1.91            3.30           2.30                 
               (-42.1 pct)     (-8.5 pct)     (+20.5 pct)              
  EPS           62.74 yen      105.00 yen      76.70 yen               
  Ann Div       70.00 yen       60.00 yen      40.00 yen               
  -Q2 Div       35.00 yen       30.00 yen      20.00 yen               
  -Q4 Div       35.00 yen       30.00 yen      20.00 yen               
  
  NOTE - Daito Pharamaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T